The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
ppar yu 1 xing tang niao bing
Author(s): 
Pages: 96-98
Year: Issue:  2
Journal: SECTION OF ENDOCRINOLOGY FOREIGN MEDICAL SCIENCES

Keyword:  过氧化物酶体增殖物活化受体γ炎症免疫调节1型糖尿病;
Abstract: 过氧化物酶体增殖物活化受体(PPARs)是受体型转录因子,属于核受体超家族.近年研究表明,在免疫细胞T细胞、B细胞、巨噬细胞上有PPARγ的表达;PPARγ可影响免疫细胞的分化及分泌,抑制巨噬细胞促炎症因子的表达,改变辅助性T细胞(Th)1/Th2细胞因子的平衡,参与炎症和免疫调节过程.PPARγ激动剂对自身免疫性疾病模型如溃疡性结肠炎、实验性自身免疫性脑脊髓炎及1型糖尿病有效.因此,PPARγ激动剂对自身免疫性1型糖尿病可能具有临床应用前景.
Related Articles
loading...